Preliminary safety results of the randomized phase II ABIDO-SOGUG trial: Toxicity profile of concomitant abiraterone acetate + docetaxel treatment in comparison to docetaxel

  1. Puente, J.
  2. Mendez Vidal, M.J.
  3. Saez, M.I.
  4. Font Pous, A.
  5. Duran, I.
  6. Castellano, D.
  7. Juan Fita, M.J.
  8. Santander, C.
  9. Arranz Arija, J.A.
  10. Sanchez-Hernandez, A.
  11. Mellado, B.
  12. Alonso, T.
  13. Gonzalez Del Alba Baamonde, M.A.
  14. Maroto, P.
  15. Lazaro, M.
  16. Esteban, E.
  17. Cassinello, J.G.
  18. Climent Duran, M.A.
Aldizkaria:
Annals of oncology : official journal of the European Society for Medical Oncology

ISSN: 1569-8041

Argitalpen urtea: 2018

Alea: 29

Orrialdeak: viii286

Mota: Artikulua

DOI: 10.1093/ANNONC/MDY284.031 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus